260 related articles for article (PubMed ID: 21281968)
1. Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes.
Martin-Chouly C; Morzadec C; Bonvalet M; Galibert MD; Fardel O; Vernhet L
Mol Immunol; 2011 Mar; 48(6-7):956-65. PubMed ID: 21281968
[TBL] [Abstract][Full Text] [Related]
2. Inorganic arsenic impairs proliferation and cytokine expression in human primary T lymphocytes.
Morzadec C; Bouezzedine F; Macoch M; Fardel O; Vernhet L
Toxicology; 2012 Oct; 300(1-2):46-56. PubMed ID: 22683347
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
4. Sodium arsenite retards proliferation of PHA-activated T cells by delaying the production and secretion of IL-2.
Galicia G; Leyva R; Tenorio EP; Ostrosky-Wegman P; Saavedra R
Int Immunopharmacol; 2003 May; 3(5):671-82. PubMed ID: 12757736
[TBL] [Abstract][Full Text] [Related]
5. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells.
Conde P; Acosta-Saavedra LC; Goytia-Acevedo RC; Calderon-Aranda ES
Arch Toxicol; 2007 Apr; 81(4):251-9. PubMed ID: 17009048
[TBL] [Abstract][Full Text] [Related]
6. Sodium arsenite reduces proliferation of human activated T-cells by inhibition of the secretion of interleukin-2.
Vega L; Ostrosky-Wegman P; Fortoul TI; Díaz C; Madrid V; Saavedra R
Immunopharmacol Immunotoxicol; 1999 May; 21(2):203-20. PubMed ID: 10319276
[TBL] [Abstract][Full Text] [Related]
7. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.
Reed JC; Alpers JD; Nowell PC; Hoover RG
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3982-6. PubMed ID: 3012540
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of arsenic on intracellular free calcium levels and the proliferative response of murine mitogen-stimulated lymphocytes.
Goytia-Acevedo RC; Cebrian ME; Calderon-Aranda ES
Toxicology; 2003 Aug; 189(3):235-44. PubMed ID: 12832156
[TBL] [Abstract][Full Text] [Related]
9. The role of the accessory cell in mitogen-stimulated human T cell gene expression.
Kern JA; Reed JC; Daniele RP; Nowell PC
J Immunol; 1986 Aug; 137(3):764-9. PubMed ID: 3088109
[TBL] [Abstract][Full Text] [Related]
10. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
[TBL] [Abstract][Full Text] [Related]
11. Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor.
Vink A; Uyttenhove C; Wauters P; Van Snick J
Eur J Immunol; 1990 Jan; 20(1):1-6. PubMed ID: 2407536
[TBL] [Abstract][Full Text] [Related]
12. Helper T cell subpopulations from women are more susceptible to the toxic effect of sodium arsenite in vitro.
Vega L; Montes de Oca P; Saavedra R; Ostrosky-Wegman P
Toxicology; 2004 Jul; 199(2-3):121-8. PubMed ID: 15147786
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells.
Lee PC; Ho IC; Lee TC
Toxicol Sci; 2005 May; 85(1):541-50. PubMed ID: 15689417
[TBL] [Abstract][Full Text] [Related]
14. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
15. The lymphokine "inhibitor of DNA synthesis" (IDS) suppresses human T lymphocyte proliferation by an interleukin-2-independent mechanism.
Reed JC; Jegasothy BV; Batra BK; Weidenfeld J; Smith DR; Nowell PC
Lymphokine Res; 1986; 5(1):11-20. PubMed ID: 3484797
[TBL] [Abstract][Full Text] [Related]
16. Thrombin enhances T cell proliferative responses and cytokine production.
Naldini A; Carney DH; Bocci V; Klimpel KD; Asuncion M; Soares LE; Klimpel GR
Cell Immunol; 1993 Apr; 147(2):367-77. PubMed ID: 8453678
[TBL] [Abstract][Full Text] [Related]
17. Global analysis of posttranscriptional gene expression in response to sodium arsenite.
Qiu LQ; Abey S; Harris S; Shah R; Gerrish KE; Blackshear PJ
Environ Health Perspect; 2015 Apr; 123(4):324-30. PubMed ID: 25493608
[TBL] [Abstract][Full Text] [Related]
18. Histamine blocks interleukin 2 (IL-2) gene expression and regulates IL-2 receptor expression.
Rezai AR; Salazar-Gonzalez JF; Martínez-Maza O; Bramhall J; Afrasiabi R; Kermani-Arab V
Immunopharmacol Immunotoxicol; 1990; 12(3):345-62. PubMed ID: 2266228
[TBL] [Abstract][Full Text] [Related]
19. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors.
Nagel JE; Chopra RK; Chrest FJ; McCoy MT; Schneider EL; Holbrook NJ; Adler WH
J Clin Invest; 1988 Apr; 81(4):1096-102. PubMed ID: 3127423
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3.
Tsoukas CD; Watry D; Escobar SS; Provvedini DM; Dinarello CA; Hustmyer FG; Manolagas SC
J Clin Endocrinol Metab; 1989 Jul; 69(1):127-33. PubMed ID: 2525134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
